Longitudinal Analysis of Adiponectin to Leptin and Apolipoprotein B to A1 Ratios As Markers of Future Airflow Obstruction and Lung Function Decline

Overview

Journal Sci Rep

Specialty Science

Date 2024 Nov 28

PMID 39604437

Authors

Seohyun Kim

Chin Kook Rhee

Yong Suk Jo

Jeong Uk Lim

Sang Hyuk Kim

Jaeeun Yoo

Joon Young Choi

Affiliations

Soon will be listed here.

Abstract

Previous studies suggest associations between the risk of developing chronic obstructive pulmonary disease (COPD) and adiponectin/leptin (ALR) and apolipoprotein B/A1 (APOR) ratios. This longitudinal observational study, using data from the Korean Genome and Epidemiology Study (KoGES), examined the rate of lung function decline, risk factors for the airflow obstruction (AFO), and the time to first AFO based on ALR and APOR groups. Among 5578 participants, high ALR and low APOR were associated with rapid decline in lung function and a shorter time to the first AFO. The high ALR group and the combined high ALR and low APOR group showed higher risk of experiencing AFO both at least once (RR 1.46, 95% CI 1.12-1.90; RR 1.74, 95% CI 1.23-2.46, respectively) and at the final follow up (RR 1.44, 95% CI 1.05-1.96; RR 1.72, 95% CI 1.14-2.60, respectively). High ALR and the combined high ALR and low APOR were identified as risk factors for earlier time to first AFO. This study highlights the potential of ALR and APOR as makers for predicting the risk of future airflow obstruction.

References

Emoto T, Sawada T, Morimoto N, Tenjin T, Wakimoto T, Ikeda F . The apolipoprotein B/A1 ratio is associated with reactive oxygen metabolites and endothelial dysfunction in statin-treated patients with coronary artery disease. J Atheroscler Thromb. 2013; 20(7):623-9. DOI: 10.5551/jat.16824. View

Heo J, Lee H, Han S, Kang H, Kwon S, Lee S . The association between serum apolipoprotein B and fractional exhaled nitric oxide in bronchial asthma patients. J Thorac Dis. 2021; 13(7):4195-4206. PMC: 8339740. DOI: 10.21037/jtd-20-3314. View

Tomoda K, Yoshikawa M, Itoh T, Tamaki S, Fukuoka A, Komeda K . Elevated circulating plasma adiponectin in underweight patients with COPD. Chest. 2007; 132(1):135-40. DOI: 10.1378/chest.07-0227. View

Assad N, Sood A . Leptin, adiponectin and pulmonary diseases. Biochimie. 2012; 94(10):2180-9. PMC: 3399062. DOI: 10.1016/j.biochi.2012.03.006. View

Martinez F, Han M, Lopez C, Murray S, Mannino D, Anderson S . Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings. JAMA. 2023; 329(6):490-501. PMC: 9929696. DOI: 10.1001/jama.2023.0128. View

Goto T, Hirayama A, Faridi M, Camargo Jr C, Hasegawa K . Obesity and Severity of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2017; 15(2):184-191. DOI: 10.1513/AnnalsATS.201706-485OC. View

Miller M, Pham A, Cho J, Rosenthal P, Broide D . Adiponectin-deficient mice are protected against tobacco-induced inflammation and increased emphysema. Am J Physiol Lung Cell Mol Physiol. 2010; 299(6):L834-42. PMC: 3006270. DOI: 10.1152/ajplung.00326.2009. View

Zapatero A, Barba R, Ruiz J, Losa J, Plaza S, Canora J . Malnutrition and obesity: influence in mortality and readmissions in chronic obstructive pulmonary disease patients. J Hum Nutr Diet. 2013; 26 Suppl 1:16-22. DOI: 10.1111/jhn.12088. View

Yao X, Gordon E, Figueroa D, Barochia A, Levine S . Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease. Am J Respir Cell Mol Biol. 2016; 55(2):159-69. PMC: 4979372. DOI: 10.1165/rcmb.2016-0060TR. View

10.

Kirdar S, Serter M, Ceylan E, Sener A, Kavak T, Karadag F . Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease. Scand J Clin Lab Invest. 2008; 69(2):219-24. DOI: 10.1080/00365510802474400. View

11.

McGhan R, Radcliff T, Fish R, Sutherland E, Welsh C, Make B . Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest. 2007; 132(6):1748-55. DOI: 10.1378/chest.06-3018. View

12.

Wu T, Ejike C, Wise R, McCormack M, Brigham E . Investigation of the Obesity Paradox in Chronic Obstructive Pulmonary Disease, According to Smoking Status, in the United States. Am J Epidemiol. 2019; 188(11):1977-1983. PMC: 6896239. DOI: 10.1093/aje/kwz185. View

13.

Fruhbeck G, Catalan V, Rodriguez A, Ramirez B, Becerril S, Salvador J . Adiponectin-leptin Ratio is a Functional Biomarker of Adipose Tissue Inflammation. Nutrients. 2019; 11(2). PMC: 6412349. DOI: 10.3390/nu11020454. View

14.

Walldius G, Jungner I . Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med. 2004; 255(2):188-205. DOI: 10.1046/j.1365-2796.2003.01276.x. View

15.

Nicholas B, Skipp P, Barton S, Singh D, Bagmane D, Mould R . Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010; 181(10):1049-60. PMC: 2874448. DOI: 10.1164/rccm.200906-0857OC. View

16.

Vernooy J, Drummen N, van Suylen R, Cloots R, Moller G, Bracke K . Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers. Thorax. 2008; 64(1):26-32. DOI: 10.1136/thx.2007.085423. View

17.

Jutant E, Tu L, Humbert M, Guignabert C, Huertas A . The Thousand Faces of Leptin in the Lung. Chest. 2020; 159(1):239-248. DOI: 10.1016/j.chest.2020.07.075. View

18.

Cirillo D, Agrawal Y, Cassano P . Lipids and pulmonary function in the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2002; 155(9):842-8. DOI: 10.1093/aje/155.9.842. View

19.

Chan K, Yeung S, Yao T, Ip M, Cheung A, Chan-Yeung M . Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2010; 14(9):1193-200. View

20.

Barochia A, Kaler M, Cuento R, Gordon E, Weir N, Sampson M . Serum apolipoprotein A-I and large high-density lipoprotein particles are positively correlated with FEV1 in atopic asthma. Am J Respir Crit Care Med. 2015; 191(9):990-1000. PMC: 4435459. DOI: 10.1164/rccm.201411-1990OC. View